Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients
Open Access
- 26 February 2008
- journal article
- viral hepatitis
- Published by Wolters Kluwer Health in Hepatology
- Vol. 47 (3) , 799-809
- https://doi.org/10.1002/hep.22076
Abstract
Interferon regulatory factor-3 (IRF-3) activation directs α/β interferon production and interferon-stimulated gene (ISG) expression, which limits virus infection. Here, we examined the distribution of hepatitis C virus (HCV) nonstructural 3 protein, the status of IRF-3 activation, and expression of IRF-3 target genes and ISGs during asynchronous HCV infection in vitro and in liver biopsies from patients with chronic HCV infection, using confocal microscopy and functional genomics approaches. In general, asynchronous infection with HCV stimulated a low-frequency and transient IRF-3 activation within responsive cells in vitro that was associated with cell-to-cell virus spread. Similarly, a subset of HCV patients exhibited the nuclear, active form of IRF-3 in hepatocytes and an associated increase in IRF-3 target gene expression in hepatic tissue. Moreover, ISG expression profiles formed disease-specific clusters for HCV and control nonalcoholic fatty liver disease patients, with increased ISG expression among the HCV patients. We identified the presence of T cell and plasmacytoid dendritic cell infiltrates within all biopsy specimens, suggesting they could be a source of hepatic interferon in the setting of hepatitis C and chronic inflammatory condition. Conclusion: These results indicate that HCV can transiently trigger IRF-3 activation during virus spread and that in chronic HCV, IRF-3 activation within infected hepatocytes occurs but is limited.Keywords
This publication has 30 references indexed in Scilit:
- Functional and Therapeutic Analysis of Hepatitis C Virus NS3·4A Protease Control of Antiviral Immune DefenseJournal of Biological Chemistry, 2007
- Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2Proceedings of the National Academy of Sciences, 2007
- Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionProceedings of the National Academy of Sciences, 2006
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in HepatocytesJournal of Biological Chemistry, 2005
- Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-IJournal of Virology, 2005
- Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signalingProceedings of the National Academy of Sciences, 2005
- Viral hepatitis CThe Lancet, 2003
- Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantationLiver Transplantation, 2003
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999